Biobamat en es it fr

Biobamat Brand names, Biobamat Analogs

Biobamat Brand Names Mixture

  • No information avaliable

Biobamat Chemical_Formula


Biobamat RX_link

No information avaliable

Biobamat fda sheet

Biobamat msds (material safety sheet)

Biobamat Synthesis Reference

No information avaliable

Biobamat Molecular Weight

309.469 g/mol

Biobamat Melting Point

< 25 oC

Biobamat H2O Solubility

Soluble as HCl salt

Biobamat State


Biobamat LogP


Biobamat Dosage Forms

Tablets (oral, 1 mg)

Biobamat Indication

Used for the symptomatic treatment of parkinsonism.

Biobamat Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Biobamat Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Biobamat side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Biobamat Patient Information

Biobamat Organisms Affected

Humans and other mammals